Data Readouts from CRISPR Trials Will Be Critical in 2019April 11, 2019Samy, Manisha
Major Pharmas Becoming Increasingly Comfortable with Gene TherapyMarch 22, 2019Zhong, Yun
CRISPR and NASH Will Be Particularly Interesting and Exciting in 2019March 15, 2019Seedhouse, Steven
Data Consistency is Important When Investing in Gene TherapyMarch 21, 2018Chattopadhyay, Debjit
Investor Interest Coming Back to BiotechMarch 19, 2018Vandermosten, John
Gene Editing Companies Have Long-Term Potential to Be M&A TargetsMarch 16, 2018Amusa, Gbola
or create an account with a social network.
or login using a social network